The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections
Top Cited Papers
Open Access
- 15 June 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (12) , 1673-1681
- https://doi.org/10.1086/420818
Abstract
Daptomycin is the first available agent from a new class of antibiotics, the cyclic lipopeptides, that has activity against a broad range of gram-posKeywords
This publication has 27 references indexed in Scilit:
- In vitro bactericidal activity of daptomycin against staphylococciJournal of Antimicrobial Chemotherapy, 2002
- National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, Issued August 2001American Journal of Infection Control, 2001
- Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpointJournal of Antimicrobial Chemotherapy, 2001
- The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolatesJournal of Antimicrobial Chemotherapy, 2001
- Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureusEmerging Infectious Diseases, 2001
- Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive PathogensAntimicrobial Agents and Chemotherapy, 2000
- In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant StrainsAntimicrobial Agents and Chemotherapy, 2000
- Optimal treatment of complicated skin and skin structure infectionsJournal of Antimicrobial Chemotherapy, 1999
- Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)Diagnostic Microbiology and Infectious Disease, 1999
- In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycinAntimicrobial Agents and Chemotherapy, 1992